Evidence map›Paper›PMID 37376228›Full record

ArticlePharmaceutics2023

Correction: Kazimir et al. Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes.

Aleksandr Kazimir, Benedikt Schwarze, Peter Lönnecke, Sanja Jelača, Sanja Mijatović, Danijela Maksimović-Ivanić, Evamarie Hey-Hawkins

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Aleksandr KazimirInstitute of Inorganic Chemistry, Faculty of Chemistry and Mineralogy, Leipzig University, 04103 Leipzig, Germany.ORCID 0000-0001-9037-1638
Benedikt SchwarzeInstitute for Medical Physics and Biophysics, Medical Faculty, Leipzig University, 04107 Leipzig, Germany.ORCID 0000-0002-5815-8703
Peter LönneckeInstitute of Inorganic Chemistry, Faculty of Chemistry and Mineralogy, Leipzig University, 04103 Leipzig, Germany.ORCID 0000-0003-1335-0897
Sanja JelačaDepartment of Immunology, Institute for Biological Research "Siniša Stanković", National Institute of Republic of Serbia, University of Belgrade, 11060 Belgrade, Serbia.ORCID 0000-0002-9848-6859
Sanja MijatovićDepartment of Immunology, Institute for Biological Research "Siniša Stanković", National Institute of Republic of Serbia, University of Belgrade, 11060 Belgrade, Serbia.
Danijela Maksimović-IvanićDepartment of Immunology, Institute for Biological Research "Siniša Stanković", National Institute of Republic of Serbia, University of Belgrade, 11060 Belgrade, Serbia.ORCID 0000-0002-8006-5079
Evamarie Hey-HawkinsInstitute of Inorganic Chemistry, Faculty of Chemistry and Mineralogy, Leipzig University, 04103 Leipzig, Germany.ORCID 0000-0003-4267-0603
Leipzig University · DEUniversity of Belgrade · RS

Funding

German Academic Exchange Service 57440919; doctoral grant for A.K.Graduate School BuildMoNa travel gants for A.K.Ministry of Science, Technological development and Innovation of the Republic of Serbia 451-03-68/2022-14/200007
6 · The paper itself

Abstract

In the original publication [...].

Identifiers

PMID37376228
PMCPMC10305583
OpenAlexW4381431588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.